A 82 years old patient was admitted for persisting abnormalities of iron metabolism parameters in the context IgG kappa monoclonal gammopathy, discovered 12 years before, and classified as MGUS (monoclonal gammopathy of undetermined significance). Serum iron and transferrin concentration were constantly extremely high (96.9 µmol/L and 5.0 g/L, respectively), transferrin saturation was elevated (77.5% ; N<45%) and serum ferritin moderately increased (608µg/L ; N<300 µg/L). Hemochromatosis was ruled out (1) : no tissue iron overload was present and genetic studies searching for mutations in HFE and non HFE genes, were negative (p.Cys282Tyr mutation, HJV (HFE2), HAMP, TFR2, BMP6, SLC40A1 and FTL). The diagnosis of monoclonal antitransferrin antibody was therefore highly suspected. A This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as an 'Accepted Article', doi: 10.1002/ajh.24004 more in depth study of iron metabolism was performed to get a better understanding of the disease.
According to Alyanakian et al (2) , we observed ( , the hepcidin/ferritin ratio was strongly decreased (<0.1-N: 4-30). These results closely remind the HFE genetic hemochromatosis profile, a condition related to a decoupling between iron status (including transferrin saturation) and hepcidin expression (4) .
In the case of circulating anti-transferrin monoclonal antibody, a disturbed interaction between transferrin iron and transferrin receptor 1 could impede iron delivery to cells, thus creating cellular iron deprivation, a condition leading an increase of transferrin synthesis.
We, therefore, explored whether the transferrin-IgG interaction disturbed the stability of the transferrin-iron complex. This was approached by quantifying abnormal forms of iron in serum. On the one hand, normal NTBI (non-transferrin bound iron) (5) concentration (<0.5µmol/L), despite high transferrin saturation, suggested that the serum transferrin increase ensured the control of all the iron present in the serum. On the other hand, high LPI (labile plasma iron) (6) 
suggested that unstable iron species, that can be engaged in oxidative stress, was present in the serum. This could be related to a weakened interaction between iron and transferrin, favored by transferrin-IgG interaction. This observation provides strong support to the fact that NTBI and LPI do not cover similar biochemical forms of iron. In this patient, no evidence of visceral iron overload or iron-related toxicity was observed. It should be noted that iron overload is inconstant in this syndrome.
In conclusion, the observed abnormalities of iron metabolism in this further case of anti-transferrin monoclonal antibody raise important questions on the way this type of monoclonal immunoglobulin impacts iron status, especially in altering transferrin-iron delivery to cells and in favoring the production of reactive plasma iron. 
